NO871939L - Fremgangsmaate for oeket ekspresjon av interleukin-2. - Google Patents

Fremgangsmaate for oeket ekspresjon av interleukin-2.

Info

Publication number
NO871939L
NO871939L NO871939A NO871939A NO871939L NO 871939 L NO871939 L NO 871939L NO 871939 A NO871939 A NO 871939A NO 871939 A NO871939 A NO 871939A NO 871939 L NO871939 L NO 871939L
Authority
NO
Norway
Prior art keywords
interleukin
procedure
increased expression
expression
increased
Prior art date
Application number
NO871939A
Other languages
English (en)
Other versions
NO871939D0 (no
Inventor
Bryan Richard Cullen
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of NO871939D0 publication Critical patent/NO871939D0/no
Publication of NO871939L publication Critical patent/NO871939L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/55—IL-2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00—Nucleic acids vectors
    • C12N2800/10—Plasmid DNA
    • C12N2800/108—Plasmid DNA episomal vectors
NO871939A 1986-05-12 1987-05-11 Fremgangsmaate for oeket ekspresjon av interleukin-2. NO871939L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/862,082 US4992367A (en) 1986-05-12 1986-05-12 Enhanced expression of human interleukin-2 in mammalian cells

Publications (2)

Publication Number Publication Date
NO871939D0 NO871939D0 (no) 1987-05-11
NO871939L true NO871939L (no) 1987-11-13

Family

ID=25337602

Family Applications (1)

Application Number Title Priority Date Filing Date
NO871939A NO871939L (no) 1986-05-12 1987-05-11 Fremgangsmaate for oeket ekspresjon av interleukin-2.

Country Status (25)

Country Link
US (1) US4992367A (no)
JP (1) JPS62278994A (no)
AR (1) AR241794A1 (no)
AT (1) AT389892B (no)
AU (1) AU603576B2 (no)
BE (1) BE1000717A5 (no)
CH (1) CH675731A5 (no)
DE (1) DE3715808A1 (no)
DK (1) DK234087A (no)
ES (2) ES2006476A6 (no)
FI (1) FI872096A (no)
FR (1) FR2598433B1 (no)
GB (1) GB2190382B (no)
GR (1) GR870727B (no)
HU (1) HU205384B (no)
IL (1) IL82475A0 (no)
IT (1) IT1215478B (no)
LU (1) LU86874A1 (no)
MC (1) MC1821A1 (no)
NL (1) NL8701132A (no)
NO (1) NO871939L (no)
NZ (1) NZ220246A (no)
PT (1) PT84849B (no)
SE (1) SE8701934L (no)
ZA (1) ZA872768B (no)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3855747T2 (de) * 1987-08-26 1997-06-12 Biogen Inc Biologische materialien, deren herstellung und verwendung in der therapie
FR2619719B1 (fr) * 1987-09-01 1991-05-10 Sanofi Sa Procede d'obtention d'interleukine-2 a partir de cellules eucaryotes, vecteurs necessaires a sa mise en oeuvre et lignees cellulaires hautement productrices
FR2636231A1 (fr) * 1988-09-09 1990-03-16 Sanofi Sa Cellules eucaryotes recombinees productrices d'interleukine-1 (beta) mature n-glycosylee, procede et vecteurs necessaires pour leur obtention et procede d'obtention d'interleukine-1 (beta) mature n-glycosylee
WO1990010069A1 (en) * 1989-02-28 1990-09-07 Institut Organicheskogo Sinteza Akademii Nauk Latviiskoi Ssr RECOMBINANT PLASMID DNA pAA 1213-23 AND pAC 262-33 CODING FOR SYNTHESIS OF HUMAN INTERLEUKIN-2, METHOD OF THEIR CONSTRUCTION AND STRAIN OF BACTERIA ESCHERICHIA COLI RRI/pAC 262-33 AS PRODUCER OF HUMAN INTERLEUKIN-2
CA2022983A1 (en) * 1989-08-11 1991-02-12 Mei-Huei Lai Expression of a functional insect specific toxin gene in mammalian cells
GB9106185D0 (en) * 1991-03-22 1991-05-08 Wellcome Found Biological control agents
US5856178A (en) * 1993-08-30 1999-01-05 Utah State University DNA cassettes for expression of lytic peptides in mammalian cells and transgenic organisms containing same
US5548075A (en) * 1993-08-30 1996-08-20 Utah State University DNA cassette and transgenic organisms carrying lytic peptide-encoding genes
US5641665A (en) * 1994-11-28 1997-06-24 Vical Incorporated Plasmids suitable for IL-2 expression
US5686246A (en) * 1995-08-03 1997-11-11 Kornman; Kenneth S. Detecting genetic predisposition to periodontal disease
CN1200037A (zh) 1995-10-17 1998-11-25 韦恩州立大学 鸡白细胞介素－15及其用途
US6001613A (en) * 1996-05-24 1999-12-14 Board Of Regents Of University Of Nebraska Plasmid bearing a cDNA copy of the genome of bovine viral diarrhea virus, chimeric derivatives thereof, and method of producing an infectious bovine viral diarrhea virus using said plasmid
AUPP655698A0 (en) * 1998-10-16 1998-11-05 Commonwealth Scientific And Industrial Research Organisation Delivery system for porcine somatotropin
US20070025958A1 (en) 2000-10-27 2007-02-01 Hadden John W Vaccine immunotherapy
KR20020043448A (ko) * 2000-12-04 2002-06-10 리송알렉스인근 인터루킨-2 재조합 단백질 및 그의 제조방법
US20040071671A1 (en) * 2001-02-20 2004-04-15 Leturcq Didier J. Cell therapy method for the treatment of tumors
HUP0402656A3 (en) * 2001-02-20 2012-03-28 Ortho Mcneil Pharm Inc A cell therapy method for the treatment of tumors

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2814039C3 (de) * 1978-03-31 1981-02-19 Gesellschaft Fuer Biotechnologische Forschung Mbh (Gbf), 3300 Braunschweig Verfahren zur Herstellung von Hybrid-Bakterien
US4405712A (en) * 1981-07-01 1983-09-20 The United States Of America As Represented By The Department Of Health And Human Services LTR-Vectors
EP0091539B2 (en) * 1982-03-31 1996-11-27 Ajinomoto Co., Inc. Gene coding for interleukin-2 polypeptide, recombinant DNA carrying said gene, cell lines possessing the recombinant DNA,and method for producing interleukin-2 using said cells
AU556353B2 (en) * 1982-12-15 1986-10-30 Ajinomoto Co., Inc. Interleukin-2 polypeptide
AU579089B2 (en) * 1983-02-08 1988-11-17 Biogen, Inc. Human interleukin-2-like polypeptides
ZA842025B (en) * 1983-03-21 1984-11-28 Hoffmann La Roche Interleuken-2
WO1985000817A1 (en) * 1983-08-10 1985-02-28 Amgen Microbial expression of interleukin ii
GB8327880D0 (en) * 1983-10-18 1983-11-16 Ajinomoto Kk Saccharomyces cerevisiae
WO1985002200A1 (en) * 1983-11-14 1985-05-23 Chiron Corporation Interleukin-2 production using cloned genes for interleukin-2 and yeast alpha-factor
FR2559782B1 (fr) * 1984-02-16 1986-07-18 Transgene Sa Vecteur d'expression dans les levures de l'interleukine-2, levures transformees et procede de preparation de l'interleukine-2
DE3574731D1 (de) * 1984-05-08 1990-01-18 Genetics Inst Ein menschlicher t-zellwachstumsfaktor.
DE3419995A1 (de) * 1984-05-29 1985-12-05 Hoechst Ag, 6230 Frankfurt Gentechnologisches verfahren zur herstellung von human-interleukin-2 und mittel zur durchfuehrung dieses verfahrens
EP0172619A1 (en) * 1984-06-20 1986-02-26 Takeda Chemical Industries, Ltd. Novel transformant and use thereof
CA1275954C (en) * 1984-08-31 1990-11-06 Hing Cheug Wong 3'-expression enhancing fragments and method
FR2583770B1 (fr) * 1985-06-21 1988-08-19 Transgene Sa Expression de l'il-2 humaine dans les cellules de mammiferes par un poxvirus recombine
FR2619719B1 (fr) * 1987-09-01 1991-05-10 Sanofi Sa Procede d'obtention d'interleukine-2 a partir de cellules eucaryotes, vecteurs necessaires a sa mise en oeuvre et lignees cellulaires hautement productrices

Also Published As

Publication number Publication date
MC1821A1 (fr) 1988-03-18
FI872096A0 (fi) 1987-05-12
ZA872768B (en) 1988-04-27
FR2598433B1 (fr) 1990-09-21
NO871939D0 (no) 1987-05-11
GR870727B (en) 1987-09-21
ES2006476A6 (es) 1989-05-01
FI872096A (fi) 1987-11-13
FR2598433A1 (fr) 1987-11-13
ATA263787A (de) 1989-07-15
GB8711072D0 (en) 1987-06-17
PT84849B (pt) 1990-02-08
AU7270387A (en) 1987-11-19
BE1000717A5 (fr) 1989-03-21
US4992367A (en) 1991-02-12
JPS62278994A (ja) 1987-12-03
SE8701934L (sv) 1987-11-13
PT84849A (pt) 1987-06-01
IT1215478B (it) 1990-02-14
DE3715808A1 (de) 1987-12-10
AU603576B2 (en) 1990-11-22
IT8720479A0 (it) 1987-05-12
CH675731A5 (no) 1990-10-31
DK234087D0 (da) 1987-05-08
LU86874A1 (fr) 1988-06-13
ES2012940A6 (es) 1990-04-16
HU205384B (en) 1992-04-28
GB2190382A (en) 1987-11-18
NL8701132A (nl) 1987-12-01
HUT45558A (en) 1988-07-28
IL82475A0 (en) 1987-11-30
AR241794A1 (es) 1992-12-30
NZ220246A (en) 1990-07-26
DK234087A (da) 1987-11-13
GB2190382B (en) 1990-08-15
AT389892B (de) 1990-02-12
SE8701934D0 (sv) 1987-05-11

Similar Documents

Publication Publication Date Title
NO870579L (no) Fremgangsmaate for fremstilling av indolizin-derivater.
NO872831D0 (no) Fremgangsmaate for fremstilling av nitrofuranderivater.
NO871939D0 (no) Fremgangsmaate for oeket ekspresjon av interleukin-2.
NO874467D0 (no) Fremgangsmaate for fremstilling av 3-pyrrolidinoler.
ES2015047B3 (es) Nuevos derivados de 18-fenilestrano.
NO870409D0 (no) Fremgangsmaate for spaltning av 1-aminoindaner.
NO870829L (no) Immortalisering av primŸrceller.
NO872255D0 (no) Fremgangsmaate for dekaffinering av raakaffe.
FI863657A0 (fi) Foerfarande foer framstaellning av n-sulfamyl-3-(2-guanidino-tiazol-4-yl-metyltio)-propionamidin.
NO873400D0 (no) Fremgangsmaate for fremstilling av sulfidfri alkalivaeske.
ES2023930B3 (es) Sintesis de ditioles.
FI860247A (fi) Foerfarande foer framstaellning av 4,4-dialkyl-2-azetidinoner.
NO870828D0 (no) Fremgangsmaate for fremstilling av biskarbamater.
NO168941C (no) Fremgangsmaate for fremstilling av mercaptoacylprolin.
NO874199D0 (no) Fremgangsmaate for fremstilling av imidazo-pyridinonderivater.
FI863883A0 (fi) Anordning foer tillslutning av flaskhals.
NO871484D0 (no) Fremgangsmaate for fremstilling av n-(sulfonylmetyl) formamider.
NO871721D0 (no) Fremgangsmaate for fremstilling av ergolenderivater.
NO880345L (no) Fremgangsmaate for fremstilling av alkyl-tert-butyletere.
FI880733A0 (fi) Anordning foer uppbaerning av solv- eller rittgarn i en vaevstol.
FI875322A0 (fi) Foerfarande foer framstaellning av 17a--hydroxi-d-homo-1,4-pregnadien-3,20-dion.
NO874698L (no) Fremgangsmaate for fremstilling av 2-guanidinothiazolderivater.
FI864790A (fi) Foerfarande foer framstaellning av 5-klor- och 5-brom-2-hydroxinikotinsyror.
FI864736A0 (fi) Foerfarande foer framstaellning av 2-substituerade 5-nitroso-4,6-diamino-pyrimidiner.
NO166361C (no) Fremgangsmaate for fremstilling av methyl-4-okso-5-tetradecynoat.